Project Grant R21MH137736
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$367K
Funding Federal Agency
National Institute of Allergy and Infectious Diseases
Awarding Federal Agency
National Institute of Mental Health
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Tallahassee, FL 32310, USA
Similar Awards
The University of Florida received a $683,625 Project Grant from the Trans-NIH Research Support program (CFDA 93.310) to develop an AI-based clinical decision support (CDS) tool that can identify women at risk for HIV and recommend HIV testing and pre-exposure prophylaxis (PrEP). The project, titled "AI-BASED CLINICAL DECISION SUPPORT TO IDENTIFY WOMEN FOR HIV TESTING AND PREP IN FLORIDA (ACTION-HIV)", aims to leverage electronic health records, social determinants of health, and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $1,576,238 to characterize, assess, and protocolize implementation strategies used by community-based organizations to improve the reach of pre-exposure prophylaxis (PrEP) and mental health/substance use (MH/SU) treatments to Latino men who have sex with men (LMSM) in Ending the HIV Epidemic (EHE)...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, provides $820,845 to New York University School of Medicine to inform policy decisions towards improving HIV outcomes across diverse settings. The project, conducted in collaboration with the Shelby County Health Department, will use mathematical modeling to simulate alternative ways to distribute resources across...
This federal Project Grant award of $1,314,701.00, issued on August 5, 2024 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to address gaps in optimizing dolutegravir-based antiretroviral therapy (ART) in children and adolescents. The primary awardee is the University of Florida, which will lead the research study. Key objectives include recruiting and enrolling 306 children and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $911,400.00 over 5 years starting August 2024 to establish the PREMISE (PREP Epidemiology, Modeling, and Surveillance) system. The goal is to use national PrEP (pre-exposure prophylaxis) data, legal/policy coding, and natural experimental designs to inform the U.S. HIV epidemic response and facilitate PrEP...
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to investigate linkages between HIV/STI prevention and syndemic behaviors in high-risk youth. The total award amount is $749,228, with a project period from September 5, 2024 to July 31, 2028. The primary objectives are to: 1) use an atheoretical, data-driven approach to analyze data from six prior HIV/STI and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to investigate the role of pioneer transcription factors in regulating HIV transcription and latency. The $1,081,920 award will support research at the University of Florida to screen a library of small hairpin RNAs (shRNAs) targeting 31 pioneer factors, in order to identify novel regulators of HIV transcription. The...
This $136,438,502 Cooperative Agreement award from the Centers for Disease Control and Prevention's HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939) supports the Florida Department of Health's comprehensive HIV prevention and surveillance efforts. The award will fund a range of evidence-based interventions from 2024 to 2029, including routine HIV and STD screening in healthcare settings, rapid linkage to care and treatment, expanding access to pre-exposure...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to enhance HIV prevention through a vaccine approach that promotes durable immunity. The $737,761 award will fund research to induce robust CD4 T follicular helper (Tfh) cells, which are essential for vigorous B cell activity within germinal centers and the production of persistent antibodies. The research will examine...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $702,000 to optimize the implementation of long-acting injectable PrEP (LAI-PrEP) in the United States. The key objectives are to: (1) identify barriers and facilitators to LAI-PrEP implementation, (2) determine optimal implementation strategies in partnership with stakeholders, and (3) pilot an implementation strategy...